Expression of SRPRA in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SRPRA is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 50.38

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

45.6

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	116.1
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	97.0
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	81.6
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	79.8
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	77.2
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	76.6
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	71.9
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	71.8
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	68.1
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	66.8
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	65.3
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	64.9
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	63.5
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	63.2
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	62.4
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	61.0
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	60.2
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	59.8
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	59.0
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	58.0
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	57.9
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	56.8
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	56.2
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	56.0
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	55.9
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	55.8
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	55.6
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	55.5
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	55.3
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	55.1
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	54.3
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	54.2
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	53.6
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	53.5
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	53.3
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	53.2
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	52.9
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	52.8
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	52.8
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	52.5
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	51.9
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	51.4
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	50.8
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	50.8
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	50.5
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	50.2
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	50.2
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	49.8
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	49.1
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	48.7
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	48.5
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	48.4
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	48.3
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	48.0
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	47.8
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	47.6
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	47.4
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	47.3
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	47.3
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	47.2
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	47.1
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	46.7
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	46.5
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	46.5
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	46.0
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	45.9
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	45.8
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	45.8
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	45.7
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	45.6
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	45.5
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	45.2
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	45.2
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	45.1
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	45.0
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	45.0
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	44.9
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	44.8
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	44.8
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	44.7
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	44.4
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	44.2
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	44.0
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	43.5
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	43.2
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	42.9
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	42.8
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	42.7
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	42.2
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	41.9
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	41.5
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	40.9
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	40.8
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	40.7
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	40.6
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	40.3
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	40.2
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	39.7
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	39.6
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	39.5
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	39.4
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	38.9
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	38.6
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	38.3
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	37.5
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	37.4
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	37.3
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	36.5
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	36.1
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	35.8
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	35.7
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	35.2
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	35.0
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	34.2
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	32.2
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	31.4
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	31.3
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	31.2
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	30.7
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	30.5
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	30.4
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	29.7
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	29.5
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	29.1
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	27.6
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	27.4
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	27.3
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	26.5
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	25.5
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	25.4
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	24.7
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	24.5
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	23.2
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	23.0
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	22.0
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	19.5
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	18.1
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	17.5
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	16.4
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	16.0
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	9.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SRPRA is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 12.35

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

15.1

Number of samples

Samples

Sample	Description	TPM
AK153	N, NA, stage:NA, dead, 240 days	28.2
AK043	N, NA, stage:NA, alive, 660 days	27.0
AK003	N, NA, stage:NA, dead, 600 days	22.6
AK218	N, NA, stage:NA, dead, 180 days	21.7
AK195	N, NA, stage:NA, dead, 390 days	21.7
AK030	N, NA, stage:NA, dead, 120 days	20.6
AK236	N, NA, stage:NA, dead, 360 days	20.5
AK188	N, NA, stage:NA, alive, 420 days	20.4
AK005	N, NA, stage:NA, dead, 240 days	20.4
AK133	N, NA, stage:NA, dead, 360 days	19.2
AK185	N, NA, stage:NA, alive, 330 days	19.1
AK205	N, NA, stage:NA, dead, 120 days	18.7
AK213	N, NA, stage:NA, alive, 2010 days	18.7
AK227	N, NA, stage:NA, alive, 300 days	18.5
AK068	N, NA, stage:NA, alive, 360 days	17.5
AK149	N, NA, stage:NA, dead, 420 days	17.3
AK072	N, NA, stage:NA, dead, 150 days	17.1
AK091	N, NA, stage:NA, dead, 210 days	16.9
AK089	N, NA, stage:NA, dead, 330 days	16.7
AK051	N, NA, stage:NA, dead, 360 days	16.6
AK085	N, NA, stage:NA, alive, 660 days	16.6
AK183	N, NA, stage:NA, alive, 360 days	16.4
AK216	N, NA, stage:NA, dead, 360 days	16.3
AK139	N, NA, stage:NA, dead, 270 days	15.8
AK117	N, NA, stage:NA, dead, 210 days	15.8
AK103	N, NA, stage:NA, alive, 1320 days	15.4
AK226	N, NA, stage:NA, dead, 360 days	15.1
AK098	N, NA, stage:NA, dead, 660 days	15.0
AK071	N, NA, stage:NA, dead, 540 days	15.0
AK079	N, NA, stage:NA, dead, 210 days	14.9
AK178	N, NA, stage:NA, dead, 240 days	14.6
AK199	N, NA, stage:NA, alive, 1860 days	14.4
AK173	N, NA, stage:NA, dead, 180 days	14.4
AK102	N, NA, stage:NA, alive, 1740 days	14.0
AK055	N, NA, stage:NA, dead, 240 days	13.9
AK100	N, NA, stage:NA, alive, 960 days	13.4
AK035	N, NA, stage:NA, dead, 210 days	13.3
AK088	N, NA, stage:NA, dead, 360 days	13.2
AK134	N, NA, stage:NA, dead, 360 days	13.2
AK167	N, NA, stage:NA, dead, 180 days	12.7
AK123	N, NA, stage:NA, dead, 180 days	12.5
AK076	N, NA, stage:NA, alive, 660 days	12.2
AK074	N, NA, stage:NA, alive, 300 days	12.1
AK053	N, NA, stage:NA, dead, 300 days	11.9
AK158	N, NA, stage:NA, dead, 360 days	11.8
AK165	N, NA, stage:NA, alive, 360 days	11.5
AK041	N, NA, stage:NA, alive, 810 days	11.4
AK099	N, NA, stage:NA, dead, 420 days	11.2
AK142	N, NA, stage:NA, alive, 90 days	10.4
AK124	N, NA, stage:NA, alive, 1920 days	10.4
AK066	N, NA, stage:NA, alive, 960 days	10.3
AK231	N, NA, stage:NA, dead, 240 days	9.6
AK002	N, NA, stage:NA, dead, 570 days	9.5
AK015	N, NA, stage:NA, alive, 720 days	9.4
AK081	N, NA, stage:NA, dead, 180 days	9.2
AK049	N, NA, stage:NA, dead, 180 days	9.2
AK156	N, NA, stage:NA, dead, 330 days	9.0
AK006	N, NA, stage:NA, dead, 360 days	7.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0168480003	Tumor	0.8
CPT0206560003	Tumor	0.8
CPT0207090003	Tumor	0.7
CPT0167970003	Tumor	0.7
CPT0224540004	Tumor	0.6
CPT0225760003	Tumor	0.6
CPT0078580003	Tumor	0.6
CPT0219080004	Tumor	0.6
CPT0217430008	Tumor	0.6
CPT0218330004	Tumor	0.6
CPT0071100003	Tumor	0.5
CPT0218690004	Tumor	0.5
CPT0206230003	Tumor	0.5
CPT0168080003	Tumor	0.5
CPT0168590003	Tumor	0.5
CPT0127480003	Tumor	0.5
CPT0125570003	Tumor	0.4
CPT0190360004	Tumor	0.4
CPT0162100003	Tumor	0.4
CPT0217060003	Tumor	0.4
CPT0206000004	Tumor	0.4
CPT0093510003	Tumor	0.4
CPT0205450004	Tumor	0.4
CPT0162020003	Tumor	0.4
CPT0217000004	Tumor	0.3
CPT0093550003	Tumor	0.3
CPT0168270003	Tumor	0.3
CPT0189750004	Tumor	0.2
CPT0093450003	Tumor	0.2
CPT0186100003	Tumor	0.2
CPT0161730003	Tumor	0.2
CPT0199770003	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0087570003	Tumor	0.2
CPT0206670004	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0171580008	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0087950003	Tumor	0.1
CPT0205570003	Tumor	0.1
CPT0201710003	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0189570004	Tumor	0.0
CPT0218960004	Tumor	0.0
CPT0196850003	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0218770003	Tumor	0.0
CPT0218830004	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0205670004	Tumor	0.0
CPT0189460003	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0217100003	Tumor	-0.1
CPT0224330003	Tumor	-0.1
CPT0168830003	Tumor	-0.1
CPT0206450003	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0189850004	Tumor	-0.1
CPT0218890004	Tumor	-0.1
CPT0123530003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0207030003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0182580003	Tumor	-0.1
CPT0168380003	Tumor	-0.1
CPT0225730003	Tumor	-0.1
CPT0087730003	Tumor	-0.1
CPT0228220003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0206110003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0104220003	Tumor	-0.1
CPT0125510003	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0087680003	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0224390004	Tumor	-0.2
CPT0167530003	Tumor	-0.2
CPT0204350003	Normal	-0.2
CPT0218670003	Tumor	-0.2
CPT0217880003	Tumor	-0.2
CPT0204390003	Normal	-0.2
CPT0205890003	Tumor	-0.2
CPT0125220003	Tumor	-0.2
CPT0182550003	Tumor	-0.2
CPT0208980003	Tumor	-0.2
CPT0206330003	Tumor	-0.2
CPT0064890003	Tumor	-0.3
CPT0206780003	Tumor	-0.3
CPT0217190003	Tumor	-0.3
CPT0204400003	Normal	-0.3
CPT0182500003	Tumor	-0.3
CPT0189250003	Tumor	-0.3
CPT0204420003	Normal	-0.3
CPT0204330003	Normal	-0.3
CPT0093590003	Tumor	-0.4
CPT0204380003	Normal	-0.4
CPT0204370003	Normal	-0.4
CPT0217710008	Tumor	-0.4
CPT0204340003	Normal	-0.5
CPT0204410003	Normal	-0.5
CPT0190240004	Tumor	-0.7
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis